University of Miami
Miami, Florida, 33136, United States
Location status: Recruiting
Location contact
Grey Freylersythe, BS
CONTACT
Tracy Crane, PhD, RDN
CONTACT
Tracy Crane, PhD, RDN
PRINCIPAL_INVESTIGATOR
NCT Number: NCT06534918
The purpose of this study is to see if survivors of breast, prostate, or colorectal cancer who receive a personal referral to a targeted nutrition and exercise program will be able to eat a healthier diet and be more physically activity.
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Not applicable
Miami, Florida, 33136, United States
Location status: Recruiting
Grey Freylersythe, BS
CONTACT
Tracy Crane, PhD, RDN
CONTACT
Tracy Crane, PhD, RDN
PRINCIPAL_INVESTIGATOR
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Inclusion criteria
- Healthcare Providers
Inclusion criteria
- Patients
Exclusion criteria
Participants will be provided with a Fitbit. Self-reported physical activity, location, vital sign and sleep stage information will be collected and monitored every day for up to eight (8) weeks. Data will be synced to the My Wellness Research Software Platform, resulting in a weekly text or phone call check-in, based on participants preference.
The nutrition course will follow a combined asynchronous and synchronous approach. The asynchronous component will consist of a pre-recorded session covering educational nutrition content, which will be made available to participants for self-paced learning. This will be followed by a synchronous, 30-60 minute live group education class on nutrition information for cancer survivors, held once per week.
The Physical Activity Program will be held virtually or in-person. This will be a 1-hour biweekly group education class on aerobic and resistance exercise recommendations for cancer survivors.
Participants will be referred to weekly one on one nutrition counseling sessions with a Registered Dietitian. The one on one sessions are anticipated to last 30-60 minutes, based on the needs of the individual.
Participants will be referred to weekly one on one exercise training sessions with an Exercise Physiologist. The one on one sessions are anticipated to last 30-60 minutes, based on the needs of the individual
Participants will receive a lifestyle medicine prescription pad, developed by the investigators, which serves as a checklist to assist participants in effectively monitoring their dietary habits and physical activity routines. Participants will also receive an 8-week text messages program which will direct participants to a webpage with nutrition and physical activity content.
Time frame: Up to 8 Weeks
Percentage of survivors who agree to participate will be reported as ≥ 50%.
Time frame: Up to 8 Weeks
Percentage of intervention sessions completed will be reported as ≥ 80%.
Time frame: Up to 8 Weeks
Report of 80% satisfaction will be determined as satisfaction with intervention components.
Contact information is provided by the study sponsor or research team.
Grey Freylersythe, BS
CONTACT
Tracy Crane, PhD, RDN
CONTACT
University of Miami
Other
Acronym: OnPoint
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06910657
Adenocarcinoma, Adnexal Diseases
St Louis, Missouri, United States
View Trial DetailsNCT07042243
Behavior, Behavior, Animal
Gainesville, Florida, United States
View Trial DetailsNCT04751435
Adnexal Diseases, Breast Cancer
Brooklyn, New York, United States
View Trial DetailsNCT06580002
Adnexal Diseases, Blood Protein Disorders
Orange, California, United States
View Trial Details